FDA Inspection 974523 — Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S — FEI 3008618737

The FDA completed an inspection of Novo Nordisk Pharmatech A/S on Jun 3, 2016 in Koge. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 3, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Koge (Denmark)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.